Biological Buffers Market Size to Reach USD 2.39 Billion by 2033 Owing to the Increasing Biopharmaceutical Production Globally | SNS Insider

U.S. Biological Buffers Market was Valued at USD 0.38 Billion in 2025 and is Expected to Reach USD 0.70 billion by 2033 Due to Rising Biologics and Vaccine Development

Austin, Jan. 20, 2026 (GLOBE NEWSWIRE) — According to SNS Insider, The Biological Buffers Market Size is estimated at USD 1.26 billion in 2025 and is expected to reach USD 2.39 billion by 2033, growing at a CAGR of 8.35% from 2026-2033. The market for biological buffers is expanding quickly as a result of growing cell and gene therapy research, growing biopharmaceutical production, and rising vaccine demand.

The U.S. Biological Buffers Market Size is estimated at USD 0.38 billion in 2025 and is expected to reach USD 0.70 billion by 2033, growing at a CAGR of 8.14% from 2026-2033. Strong biopharmaceutical production, growing biologics and vaccine development, and growing cell and gene therapy research are the main factors propelling the biological buffers market in the U.S. Demand for dependable, high-quality buffer solutions is rising due to increased R&D expenditures, an increase in diagnostic testing, and stricter regulations.

Get a Sample Report of Biological Buffers Market Forecast @ https://www.snsinsider.com/sample-request/9290

Rising Investments in Biopharmaceutical Research to Boost Market Growth Globally

The growing need for sophisticated therapies, biologics, and precision medicines has led to a large increase in global spending in biopharmaceutical research and life sciences. Biological buffers are essential for preserving the ideal pH and stability during protein analysis, medication formulation, and biochemical reactions. High-purity buffers are necessary for academic labs, research facilities, and pharmaceutical businesses to guarantee regulatory compliance and experimental precision. The demand for dependable biological buffer solutions in a variety of laboratory settings around the world is being accelerated by increased R&D funding, the growth of contract research companies, and the expansion of biotech entrepreneurs.

Major Players Analysis Listed in the Biological Buffers Market Report

• Thermo Fisher Scientific Inc.
• Merck KGaA
• Avantor, Inc.
• Lonza Group AG
• FUJIFILM Irvine Scientific, Inc.
• Bio-Rad Laboratories, Inc.
• Takara Bio Inc.
• GE Healthcare Life Sciences (Cytiva)
• PAN-Biotech GmbH
• MP Biomedicals, LLC
• Gold Biotechnology, Inc.
• Spectrum Chemical Manufacturing Corp.
• Alfa Aesar (Thermo Fisher Scientific)
• HiMedia Laboratories, Inc.
• Carl Roth GmbH + Co. KG
• AppliChem GmbH
• Tokyo Chemical Industry Co., Ltd. (TCI)
• Sisco Research Laboratories Pvt. Ltd. (SRL)
• Santa Cruz Biotechnology, Inc.
• Promega Corporation

Biological Buffers Market Segmentation Analysis

By Product Type

Phosphate Buffers led with 39.6% share due to their wide compatibility with biological systems, stable pH control, and extensive use across cell culture, molecular biology, and diagnostic workflows. HEPES Buffers are the fastest-growing segment with CAGR of 11.8% due to their superior buffering capacity in physiological pH ranges and strong performance under open-air and temperature-variable conditions.

By Form

Powder led with 52.4% share due to their long shelf life, ease of storage, and cost efficiency for bulk laboratory and manufacturing use. Liquid is the fastest-growing segment with CAGR of 10.9% due to increasing demand for ready-to-use solutions that improve operational efficiency and reduce preparation errors.

By Application

Cell Culture led with 41.7% share as it is foundational to biological research, drug discovery, vaccine development, and biopharmaceutical production. Biopharmaceutical Manufacturing is the fastest-growing segment with CAGR of 12.3% due to rising global production of biologics, biosimilars, and advanced therapies.

By End-User

Biopharmaceutical Companies led with 44.8% share as they consume buffers across the entire product lifecycle, from early-stage research to commercial-scale manufacturing. Contract Research Organizations (CROs) are the fastest-growing segment with CAGR of 11.6% due to increasing outsourcing of drug discovery, development, and analytical testing activities.

By Region, North America Dominated with the Biggest Market Share in 2025 and Asia Pacific is Expected to Grow with the Fastest CAGR in the Market During 2026-2033

North America dominated the Biological Buffers Market with a 36.00% share in 2025 due to strong biopharmaceutical manufacturing capacity, high R&D spending, and the presence of leading life sciences companies. 

Asia Pacific is expected to grow at the fastest CAGR of about 10.39% from 2026–2033, driven by expanding biopharmaceutical production, rising research activities, and increasing investments in biotechnology and life sciences.

Get Expert-Led Insights for Your Business Strategy — Connect with Analysts Now @ https://www.snsinsider.com/request-analyst/9290

Biological Buffers Market Recent Developments

• April 2024, Thermo Fisher launched the Connect Lab Intelligence Platform, a unified digital ecosystem that integrates instruments, data, and supplies across the lab workflow.
• November 2023, Merck KGaA (operating its life science business as MilliporeSigma) launched GreenLab, a comprehensive program offering eco-designed reagents, solvents, and lab plastics with verified sustainability metrics.

Exclusive Sections of the Report (The USPs)

• WATER & ENERGY INTENSITY METRICS – helps you benchmark water and power consumption per unit of buffer produced, highlighting efficiency gaps and sustainability performance across manufacturers.
• ECO-FRIENDLY PACKAGING ADOPTION RATE – helps you assess the industry shift toward recyclable, reduced-plastic, and sustainable packaging formats in buffer distribution.
• WASTE REDUCTION IMPACT FROM CONCENTRATED & SINGLE-USE BUFFERS – helps you understand how modern buffer formats minimize chemical waste, handling losses, and disposal costs.
• RECYCLABLE CONTAINER UTILIZATION IN BULK SUPPLY – helps you evaluate sustainability practices in large-scale buffer supply chains, especially for biopharma manufacturing facilities.
• SUSTAINABILITY REPORTING PENETRATION – helps you gauge the maturity of ESG adoption among buffer manufacturers through formal sustainability disclosures and compliance initiatives.

Biological Buffers Market Report Scope

Report Attributes	Details
Market Size in 2025E	USD 1.26 Billion
Market Size by 2033	USD 2.39 Billion
CAGR	CAGR of 8.35% From 2026 to 2033
Base Year	2025
Forecast Period	2026-2033
Historical Data	2022-2024
Key Segments	• By Product Type (Phosphate Buffers, Tris Buffers, HEPES Buffers, Citrate Buffers, Acetate Buffers) • By Form (Powder, Liquid, Tablets) • By Application (Cell Culture, Protein Purification, Molecular Biology, Biopharmaceutical Manufacturing, Diagnostic Testing) • By End User (Biopharmaceutical Companies, Academic & Research Institutes, Contract Research Organizations (CROs), Diagnostic Laboratories, Hospitals & Clinical Laboratories)
Regional Analysis/Coverage	North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America).

Purchase Single User PDF of Biological Buffers Market Report @ https://www.snsinsider.com/checkout/9290

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

CONTACT: Contact Data
Contact Us:
Rohan Jadhav - Principal Consultant
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaEveningPost.com takes no editorial responsibility for the same.